Pamidronic Acid
Back to searchMolecule Structure
Scientific Name
Pamidronic Acid
Description of the Drug
Pamidronic acid is a bisphosphonate used to treat Paget’s disease, to treat hypercalcemia of malignancy, and to treat osteolytic bone lesions.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00282
http://www.drugbank.ca/drugs/DB00282
Brand Name(s)
Not Available
Company Owner(s)
Mn Pharmaceuticals, Fresenius Kabi Usa Llc, Sun Pharma Global Inc, Mylan Laboratories Ltd, Sagent Pharmaceuticals Inc, Hospira Inc, American Regent Inc, Aesgen Inc, Teva Pharmaceuticals Usa, Dr Reddys Laboratories Ltd
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Farnesyl diphosphate synthase | SINGLE PROTEIN | INHIBITOR | CHEMBL1782 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL18361 | ||
PharmGKB | PA450767 | ||
Human Metabolome Database | HMDB0014427 | ||
DrugBank | DB00282 | ||
PubChem: Thomson Pharma | 14798245 | ||
PubChem | 44400012 | 4674 | |
Mcule | MCULE-4373491291 | ||
Nikkaji | J221.669H | ||
PDBe | 210 | ||
BindingDB | 12581 | ||
EPA CompTox Dashboard | DTXSID4023414 | ||
DrugCentral | 2048 | ||
Brenda | 212813 | 7519 | |
ChemicalBook | CB8107554 | ||
Guide to Pharmacology | 7259 | ||
rxnorm | PAMIDRONATE DISODIUM | PAMIDRONATE | PAMIDRONIC ACID |
KEGG Ligand | C07395 | ||
ChEBI | 7903 | ||
ZINC | ZINC000003812862 |